Target Name: NDUFS5
NCBI ID: G4725
Review Report on NDUFS5 Target / Biomarker Content of Review Report on NDUFS5 Target / Biomarker
NDUFS5
Other Name(s): OTTHUMP00000008670 | NADH-ubiquinone oxidoreductase 15 kDa subunit | NADH:ubiquinone oxidoreductase 15 kDa IP subunit | NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 | NADH:ubiquinone oxidoreductase subunit S5 | Complex I-15 kDa | CI15K | NDUS5_HUMAN | NADH:ubiquinone oxidoreductase subunit S5, transcript variant 1 | CI-15k | NDUFS5 variant 1 | CI-15 kDa | NADH dehydrogenase (ubiquinone) Fe-S protein 5 | complex I-15 kDa | OTTHUMP00000008671 | NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)

Native Domain-Driven Unit-based Extensible Framework for Synthetic Biology

Introduction

The development of new therapeutic approaches for diseases is a critical need for the healthcare industry. One of the promising approaches is the use of synthetic biology, which is a systems-level approach to identify, design, and create synthetic biological systems. One of the Key challenges in synthetic biology are the development of efficient and reliable methods for creating and characterizing synthetic biological systems.

One of the solutions to this problem is the Native Domain-Driven Unit-based Extensible Framework for Synthetic Biology (NDUFS5), which is a synthetic biology tool that can be used to design, build, and characterize synthetic biological systems. In this article, we will explore theNDUFS5 framework and its potential as a drug target or biomarker.

TheNDUFS5 Framework

NDUFS5 is a synthetic biology tool that is designed to simplify the process of creating synthetic biological systems. It is based on the concept of a \"domain-driven\" approach, where the problem is divided into smaller, domain-specific parts that can be addressed by domain-specific tools.

TheNDUFS5 framework consists of several components, including:

1. The Synthetic Biology Platform: This is a modular and reconfigurable platform that can be used to create synthetic biological systems. It consists of a set of libraries and a framework for designing and building synthetic biological systems.

2. The Domain-Specific toolbox: This is a tool that is used to design and build synthetic biological systems for a specific domain. It provides a set of libraries and a framework for designing and building synthetic biological systems for a specific domain.

3. The Synthetic Biology Model: This is a mathematical model that describes the synthetic biology system. It is used to simulate and analyze the behavior of the synthetic biology system.

4. The Synthetic Biology Simulator: This is a tool that is used to simulate and analyze the behavior of the synthetic biology system. It is based on the Synthetic Biology Platform and the Synthetic Biology Model.

TheNDUFS5 framework is based on a \"domain-driven\" approach, where the problem is divided into smaller, domain-specific parts that can be addressed by domain-specific tools. This allows for the development of efficient and reliable methods for creating and characterizing synthetic biological systems.

Potential Applications

NDUFS5 has the potential to be used as a drug target or biomarker in several ways.

1.Drug Target

One of the potential applications of NDUFS5 is as a drug target. Synthetic biology technology can be used to design, construct and modify drug targets, thereby providing new tools and approaches for drug development. By interacting NDUFS5 with drug molecules, drug molecule interactions can be predicted and drug design and screening optimized. In addition, NDUFS5 can also be used to design microbial strains for drug production and optimize the production process, thereby reducing production costs.

2. Biomarkers

NDUFS5 can also be used as a biomarker. By using NDUFS5 for the design and construction of biomarkers, the expression level, stability, and specificity of biomarkers can be predicted, thereby improving the accuracy and reliability of biomarkers. In addition, NDUFS5 can also be used to study the association between biomarkers and diseases and develop new diagnostic methods and treatment options.

Conclusion

In conclusion, the Native Domain-Driven Unit-based Extensible Framework for Synthetic Biology (NDUFS5) has the potential to be a valuable tool for drug target development and biomarker research. By using NDUFS5, researchers can design, build, and characterize synthetic biological systems for a specific domain, and use these systems as drug targets or biomarkers for a variety of diseases. With its modular and reconfigurable design, NDUFS5 can be used to address the challenges of synthetic biology and accelerate the development of new therapeutic approaches.

Protein Name: NADH:ubiquinone Oxidoreductase Subunit S5

Functions: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

The "NDUFS5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NDUFS5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NDUFS6 | NDUFS7 | NDUFS8 | NDUFV1 | NDUFV2 | NDUFV2P1 | NDUFV3 | NEAT1 | NEB | NEBL | NECAB1 | NECAB2 | NECAB3 | NECAP1 | NECAP2 | NECTIN1 | NECTIN2 | NECTIN3 | NECTIN3-AS1 | NECTIN4 | NEDD1 | NEDD4 | NEDD4L | NEDD8 | NEDD8-activating enzyme E1 | NEDD8-MDP1 | NEDD9 | NEFH | NEFHP1 | NEFL | NEFM | NEGR1 | NEGR1-IT1 | NEIL1 | NEIL2 | NEIL3 | NEK1 | NEK10 | NEK11 | NEK2 | NEK2-DT | NEK3 | NEK4 | NEK5 | NEK6 | NEK7 | NEK8 | NEK9 | NELF Complex | NELFA | NELFB | NELFCD | NELFE | NELL1 | NELL2 | NEMF | NEMP1 | NEMP2 | NEMP2-DT | NENF | NEO1 | NEPRO | NES | NET1 | NETO1 | NETO1-DT | NETO2 | Netrin receptor | NEU1 | NEU2 | NEU3 | NEU4 | NEURL1 | NEURL1-AS1 | NEURL1B | NEURL2 | NEURL3 | NEURL4 | NEUROD1 | NEUROD2 | NEUROD4 | NEUROD6 | NEUROG1 | NEUROG2 | NEUROG3 | Neuromedin U Receptor | Neuronal acetylcholine receptor alpha2beta2 receptor | Neuronal Acetylcholine Receptor alpha3alpha5beta2 Receptor | Neuropeptide FF Receptor | Neuropeptide Y receptor (NPY-R) | Neurotensin receptor | Neurotrophic Factor | Neurotrophic Tyrosine Kinase Receptor (TRK) | NEXMIF | NEXN | NEXN-AS1 | NF-kappaB (NFkB) | NF1 | NF1P1 | NF1P2